| Year |
Citation |
Score |
| 2023 |
Chandasana H, Thapar M, Hayes S, Baker M, Gibb DM, Turkova A, Ford D, Ruel T, Wiznia A, Fairlie L, Bwakura-Dangarembizi M, Mujuru H, Alvero C, Farhad M, Hazra R, ... ... Singh R, et al. Population Pharmacokinetic Modeling of Dolutegravir to Optimize Pediatric Dosing in HIV-1-Infected Infants, Children, and Adolescents. Clinical Pharmacokinetics. PMID 37603217 DOI: 10.1007/s40262-023-01289-5 |
0.312 |
|
| 2021 |
Singh RP, Adkison KK, Baker M, Parasrampuria R, Wolstenholme A, Davies M, Sewell N, Brothers C, Buchanan AM. Development of Dolutegravir Single-entity and Fixed-dose Combination Formulations for Children. The Pediatric Infectious Disease Journal. PMID 34817414 DOI: 10.1097/INF.0000000000003366 |
0.325 |
|
| 2016 |
Singh RP, Garg N, Nar AS, Mahajan A, Mishra A, Singh J, Ahuja A, Bawa A. Role of amylase and lipase levels in diagnosis of blunt trauma abdomen Journal of Clinical and Diagnostic Research. 10: PC20-PC23. DOI: 10.7860/JCDR/2016/14346.7308 |
0.331 |
|
| 2015 |
Pan SJ, Tapley A, Adamson J, Little T, Urbanowski M, Cohen K, Pym A, Almeida D, Dorasamy A, Layre E, Young DC, Singh R, Patel VB, Wallengren K, Ndung'u T, et al. Biomarkers for Tuberculosis Based on Secreted, Species-Specific, Bacterial Small Molecules. The Journal of Infectious Diseases. PMID 26014799 DOI: 10.1093/Infdis/Jiv312 |
0.369 |
|
| Show low-probability matches. |